01P — Medpace Holdings Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeLarge CapNeutral

Annual income statement for Medpace Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	926	1,142	1,460	1,886	2,109
Cost of Revenue
Gross Profit	279	328	432	525	656
Selling / General / Administrative Expenses
Depreciation and Amortization
Total Operating Expenses	759	944	1,181	1,549	1,662
Operating Profit	167	199	279	337	447
Total Net Non Operating Interest Income / Expense
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	169	202	283	336	476
Provision for Income Taxes
Net Income After Taxes	145	182	245	283	404
Net Income Before Extraordinary Items
Net Income	145	182	245	283	404
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	145	181	245	283	404
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	3.84	4.81	7.28	8.88	12.6